Promising New Trial for Relapsed B-Cell Lymphoma

B cell lymphoma is notoriously unresponsive when it returns after treatment. Scientists at City of Hope are aiming to give patients with relapsed B cell lymphoma another chance at beating cancer in a new trial involving T cells.

Of the 30 types of non-Hodgkin lymphomas, B cell is the most common and one of the most difficult to treat. T cells are a family of white blood cells that can be genetically modified to fight diseases including cancer.

In order to target B cell lymphomas, the new trial will focus on a protein produced inside the lymphoma cells, CD19. In the study, the T cells will be developed to treat lymphoma and will be attracted to the CD19 protein.

“Our use of central memory T cells as part of an autologous transplant is unique to our therapy and sets our approach apart from other T cell treatments in development,” said Stephen J. Forman, chair of City of Hope’s department of Hematology.

“T cells have the potential to establish a persistent, lifelong immunity to help prevent recurrence of lymphoma after transplant.”

The T cells in the study will be obtained from the patient’s own healthy cells. They will then be genetically modified to recognize the CD19 protein and target the lymphoma cells, and then cultured for a few weeks to increase their numbers to a level that can fight the B cell lymphoma in the patient.

The scientists involved in the clinical trial hope that the T cells will become part of a cancer fighting immune system that will develop after transplant and help prevent recurrence of lymphoma. This could be a step toward a cure for relapsed B cell lymphoma.

This study was published in the City of Hope magazine, City News

More Articles

More Articles

Mantle cell lymphoma (MCL) is a rare type of B-Cell lymphoma. It presents itself in the mantle zone of lymph nodes...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

Indolent Lymphoma, or Indolent Non-Hodgkin’s Lymphomas (NHLs), are slow growing, low-grade cancers (as opposed to ...

A lymphoma prognosis varies greatly depending on the type of lymphoma. There are more than 35 types of lymphoma, including 5 types of...

Lymphomas are classified based on the type of cells involved. Non-Hodgkin’s lymphomas are marked by mutations of...

Hodgkin's Lymphoma (Disease) has a colorful history: It was not the first cancer discovered but it was one of the first in which treatments were...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

Cancer bracelets are undeniably popular, and if purchased through reliable sources such as major charities, they help contribute to the fight...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Lymphoma is a cancer of the b- and t-cell lymphocytes, part of the immune system. They account for the most frequent head and neck malignancies....

Lymphoma is a cancer of the lymphatic system, causing B-cell or...

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster...

As a kind of cancer, lymphoma attacks the lymphocytes and lymph nodes that are part of the immune system. Head and neck lymphoma results when...

Some cancers have clear environmental causes. Oral cancer is strongly tied to the use of chewing tobacco, and lung cancer is well-known to be much...

The Follicular Lymphoma International Prognostic Index, or FLIPI, is a standardized guide to help oncological diagnosticians accurately calculate...